This randomized controlled trial aims to evaluate the effectiveness of virtual reality-guided imagery in reducing pain, anxiety, and fatigue among female breast cancer patients undergoing adjuvant chemotherapy. Participants will be randomly assigned to either an intervention group receiving virtual reality-guided imagery in addition to routine care, or a control group receiving routine care
Female patients aged 18 years or older.
Histologically confirmed breast cancer.
Stage I, II, or III breast cancer.
Underwent surgery as the initial treatment and are scheduled to receive the first cycle of adjuvant chemotherapy, with or without biologic therapy (e.g., AC or TC regimens).
Visual or hearing impairment that prevents the use of virtual reality.
Serious neurological or psychiatric disorders.
Current participation in other non-pharmacological interventions (e.g., meditation or relaxation therapy) that could influence the study outcomes.
Previous experience with virtual reality-guided imagery.
Thoalfokar Mohammed Al-Obaidi
Lead sponsor
University of Baghdad
Sponsor institution